T1	Participants 118 228	ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy
T2	Participants 356 488	patients who achieve a pathological complete remission (pCR) at second-look surgery but in whom a high rate of relapses still occurs
T3	Participants 513 572	153 patients in pCR following platinum-based intravenous CT
T4	Participants 960 983	age (median = 55 years)
T5	Participants 985 1145	performance status (78% P.S. O), FIGO stage (96% stage III), histology (serous in 66%), grade (2 or 3 in 80%), and residuum before intravenous CT (>1 cm in 40%)
